Telemedicine Follow-Up from Shanghai After Returning Home: 2026 Guide

Continuity of Care After Returning Home

Cancer treatment doesn't end when you fly home. Follow-up imaging, lab work, prescription refills, and management of late side effects require ongoing coordination between your Shanghai treating team and local doctors. MedBridge provides structured telemedicine follow-up programs.

What Remote Follow-Up Covers

Scheduled video consultations with your Shanghai oncologist/surgeon at 1, 3, 6, and 12 months post-treatment

Review of local imaging and labs: You get CT/MRI/blood work done at home; MedBridge translates and forwards to Shanghai; Shanghai doctor provides written assessment

Prescription coordination: For Chinese-developed drugs (zanubrutinib, pamiparib, furmonertinib, camrelizumab) not available in your country, MedBridge can coordinate legitimate supply through authorized channels where legally permitted

Late side effect management: Cardiac, pulmonary, neuropathy, endocrine issues after chemo/radiation

Survivorship care plan: Written long-term monitoring schedule

Second opinion on recurrence or new findings: Rapid review within 3-5 business days

How It Works

Before discharge, MedBridge establishes your follow-up schedule and identifies your Shanghai doctor's preferred communication channel

At each follow-up point, you receive a reminder with local test requirements

You get tests done at a local facility, upload reports/images

MedBridge translates and forwards to Shanghai

Scheduled video consultation (Russian/Korean/Japanese interpreter present)

Written recommendations delivered in your language

If in-person visit is recommended, MedBridge arranges fast-track return to Shanghai

Technology

Video consultations via hospital-approved platforms or WeChat (common in Chinese clinical practice)

MedBridge uses a secure, PIPL-compliant patient portal for document exchange

Interpreters join every call

All follow-up records are maintained and accessible

When to Return in Person

Suspicion of recurrence requiring advanced imaging or biopsy

New treatment decision (e.g., switching therapy line)

Procedure or surgery

Clinical trial enrollment

Annual comprehensive review (recommended for high-risk patients)

Cost Reference

Single video follow-up with interpreter and written report: ¥1,500–3,500

Annual follow-up package (4 scheduled consultations + document translation + care coordination): ¥15,000–30,000

Urgent second opinion review (within 3-5 business days): ¥3,000–6,000

In-person return trip coordination: custom quote based on treatment plan